Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
- 1 November 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 9 (6) , 798-801
- https://doi.org/10.1161/01.atv.9.6.798
Abstract
Clotting Factor VII activity emerges as a highly significant predictive factor for development of cardiovascular disease (CVD) in prospective trials. We have previously shown that in hypertriglyceridemic individuals a fraction of their clotting Factor VII molecules is present in an activated state in phospholipase C-sensitive complexes in plasma. These complexes may explain the increased Factor VII activity observed to be a predictive factor for CVD. We demonstrate here that the level of such complexes is amenable to dietary intervention and that the alteration in Factor VII complex levels correlates closely with the corresponding alteration in triglycerides.This publication has 17 references indexed in Scilit:
- Factor VII-Phospholipid Complex in Male Survivors of Acute Myocardial InfarctionActa Medica Scandinavica, 2009
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- A new form of coagulation factor VII in plasmaScandinavian Journal of Haematology, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- A novel form of factor VII in plasma from men at risk for cardiovascular diseaseBritish Journal of Haematology, 1985
- Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIain hyperlipidaemia, with possible implications for ischaemic heart diseaseBritish Journal of Haematology, 1985
- Triglycerides—Main Lipid Risk Factor for Cardiovascular Disease in Women?Acta Medica Scandinavica, 1985
- Risk Factors for Ischaemic Heart Disease in Men and Women: Results of the 19‐Year Follow‐up of the Stockholm Prospective StudyActa Medica Scandinavica, 1985
- HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITYThe Lancet, 1983
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980